Recently, it was also demonstrated that TKI-induced EGFR dimerization is a critical mechanism for facilitating acquired resistance in cells harboring EGFR T790M mutation and that targeted reduction of EGFR resulted in tumor regression [57]. The gene discussed is EGFR; the disease is neoplasm.